Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NovoBliss has completed over 60 clinical trials on consumer goods including oral care, eye care, cosmetics, food supplements, nutraceuticals, skin care, hair care, and baby care. Their published work includes method development for evaluating new hair growth and scalp health in androgenetic alopecia patients. Ongoing trials include safety/efficacy of herbal/non-herbal formulations for hair fall/hair growth/premature graying; validation of dermatology methodologies; process validation in wound creation/treatment efficacy. No late-stage pharmaceutical assets reported.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NovoBliss Research.